Back to Search
Start Over
Lonza to make drug active for Aurinia.
- Source :
-
C&EN Global Enterprise . 1/9/2017, Vol. 95 Issue 2, p12-13. 2p. - Publication Year :
- 2017
-
Abstract
- The article reports that the biotechnology firm Lonza has signed an agreement to manufacture voclosporin for use by the biotech firm Aurinia in a Phase III clinical trial of the drug as a lupus nephritis treatment and mentions optimization of the drug's complex manufacturing process.
- Subjects :
- *CLINICAL drug trials
Subjects
Details
- Language :
- English
- ISSN :
- 24747408
- Volume :
- 95
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- C&EN Global Enterprise
- Publication Type :
- Periodical
- Accession number :
- 120728417
- Full Text :
- https://doi.org/10.1021/cen-09502-buscon008